NanoViricides
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -129 | -133 | -132 |
EBITDA | -1,859 | -2,087 | -1,652 |
EBIT | -1,989 | -2,220 | -1,785 |
Net Income | -1,989 | -2,220 | -1,785 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,930 | -2,049 | -1,678 |
Cash | 3,213 | 5,150 | 1,125 |
Basic Shares | 21,609 | 19,850 | 17,082 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -743 | -759 | -747 |
EBITDA | -8,723 | -7,485 | -7,840 |
EBIT | -9,466 | -8,244 | -8,587 |
Net Income | -9,466 | -8,294 | -8,588 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -8,535 | -6,472 | -5,821 |
Cash | 1,558 | 4,797 | 8,149 |
Basic Shares | 15,117 | 11,871 | 11,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.10 |
2026-03-31 | -$0.09 |
2025-12-31 | -$0.11 |
2025-09-30 | -$0.10 |